Weikang Bio-Technology Group (fka WKBT)

[pappy]

While I didn't like that the private placement was done @$2.40 it did increase the float by over 2M shares.

A bigger float was needed to attract institutional interest once listing occurs.

I haven't took the time to look at the impact on stated preliminary eps estimate of $1.04 if any.

Since the pp wasn't completed until after 2010 results I assume the extra shares won't show until 2011 financial results.

It will be interesting how they proceed once listed as they have said they have a number of acquisitions they are considering after listing occurs.

Listing & institutional support could really get the pps moving in the right direction as I see no reason that wkbt won't become a institutional favorite as they try to enlist their money for planned growth via acquisition further increasing the float while becoming a much bigger force in Chinas pharm. industry.

Consolidation of the China pharm. industry is coming & wkbt with its strong organic growth thru 10% R&D spending developing a steady flow of new products will be in good position to grow in that direction also.

I maybe getting ahead of things since the pps needs to go up a bit more & once 2010 audited results get investor attention I agree we should be around $5.

Good luck to wkbt investors & hang in there as I believe wkbt has a very bright future.